Your Partner in Advanced Therapy Development and Manufacturing
End-to-end ATMP solutions — from early development to clinical manufacturing. Acting as an extension of your team, Cellab CDMO delivers integrated cell & gene therapy solutions from bench to bedside.
A specialized advanced-therapy CDMO
Cellab CDMO combines cell banking and GMP manufacturing under a unified quality framework — a fully integrated, end-to-end model supporting your therapy from early development to clinical application.
We ensure alignment across process development, starting material sourcing, manufacturing, cryopreservation, quality and regulatory requirements — reducing complexity and accelerating your path to the clinic.
Broad expertise across advanced therapy platforms
We support a broad range of advanced therapy modalities — from autologous and allogeneic cell therapies to gene-modified products.
Mesenchymal stem cells
Gene-modified cell therapies
Hematopoietic stem & progenitor cells
Immune cell therapies
Induced pluripotent stem cells
Additional advanced therapies
From bench to bedside
We adapt our approach to your therapy stage, ensuring the right strategy from bench to bedside.
Early Development
Process design, scalability and initial strategy.
Preclinical
GMP transition and QC strategy.
Clinical Stage
GMP manufacturing and regulatory support.
Starting material sourcing
Accredited AABB cell bank; assessment of objectives to identify the most suitable starting material.
GMP Cell Bank
Fully regulated environment with 24/7 monitoring for quality, security and traceability.
Integrated, end-to-end CDMO services
Tailor-made services from bioprocess scaling to GMP batch release and QP release across Europe.
R&D and Process Development
Design and optimization of scalable, GMP-compliant processes, including mechanism of action-driven potency assays. Seamless transition from early development to GMP manufacturing; process optimization to improve efficiency and reduce costs; collaborative, hands-on approach integrated with your team.
- Process scale-up
- MoA-driven potency assays
- Hands-on team integration
Why choose Cellab
A trusted partner combining scientific rigor, GMP quality and end-to-end delivery for cell & gene therapy programs.
Extension of your team
We integrate closely — supporting strategic decisions, process optimization and problem-solving throughout development.
Integrated end-to-end model
From development to clinical manufacturing, we align every stage — reducing fragmentation and accelerating timelines.
Scientific & technical expertise
Deep specialization in preserving sensitive biological materials while maintaining viability and potency.
Quality & regulatory excellence
GMP and AABB accreditations ensure high standards of compliance, traceability and product quality.
Cryopreservation expertise
Long track record in cryopreservation and cell banking under strict quality frameworks.
Reliable, agile logistics
Temperature-controlled international transport of biological samples and ATMPs, including time-critical shipments.
EU QP Release
Efficient European batch release of ATMPs, ensuring full regulatory alignment and rapid market readiness.
State-of-the-art infrastructure for ATMP manufacturing
Our purpose-built facility supports the complete ATMP lifecycle. Over 1,000 m² combining advanced technology with smart facility design to ensure efficiency, flexibility and regulatory compliance.
All areas operate under a robust Quality Management System, with validated equipment and full traceability. The modular, independent cleanroom design enables parallel manufacturing activities.
Who we partner with & proven expertise
We collaborate with international biotech and pharmaceutical companies, hospitals and research institutions to bring advanced therapies to the clinic.
Who we work with
Trust & credibility
- GMP-compliant manufacturing
- AABB-accredited cell banking
- 10+ years in cell processing & cryopreservation
- Experience supporting clinical-stage products
- Support for autologous and allogeneic therapies
Scientific leadership
Experienced professionals with deep understanding of GMP requirements, regulatory standards and industry best practices.
Alexandre Marfany Pluchart
CEO since 2020, leading strategic growth and innovation. BSc in Business Administration with 5+ years of company management.
Alba Casamayor Genescà, PhD
With Cellab since 2013. 15+ years in ATMP research and GMP manufacturing, QC and AABB-standard cell/tissue banks. PhD in Biotechnology.
Ariadna Sanglas Baulenas
Head of Quality Control since 2025. PhD in Biotechnology (UB), ISO 13485 and BSL-2 lab experience.
Raquel Calderon Almendro, PhD
10+ years in pharma QA/QP under GMP. BSc Pharmacy, MSc Pharma Industry, PhD Biomedical Chemistry.
Clara Boces Pascual, PhD
Since 2020. PhD in Biomedicine, 10+ years in process development of GMP biological therapies.
Claudia Pujol Bonaparte
Since 2016. BSc Chemistry, MSc Pharma Industry. 10+ years processing ATMPs under GMP and AABB.
Paul Starz
Since 2024. MSc Biochemistry / Biomedicine. Bridges science and business to advance novel ATMPs.
Get expert feedback on your therapy
Share a few details about your program and our scientific team will get back to you with tailored insights on process, GMP transition, QC and regulatory strategy.
Let's discuss your therapy
Speak with our scientific team about your ATMP program, request a technical call or explore a partnership.
Sant Julià de Lòria — Principat d'Andorra